Montelukast sodium市场规模、份额及成长分析（按剂型、应用及地区划分）－2026-2033年产业预测

预计到 2024 年，全球Montelukast sodium市场规模将达到 5,273.9 亿美元，到 2025 年将成长至 6,070.2 亿美元，到 2033 年将成长至 18,698.6 亿美元，预测期（2026-2033 年将成长至 18,698.6 亿美元，预测期（2026-2033 年）的复合年增长率为 15.1%。

全球Montelukast sodium市场正经历显着成长，主要受气喘和过敏性鼻炎等呼吸系统疾病盛行率上升以及人口老化（老年人更容易患上这些疾病）的推动。日益严重的空气污染加剧了过敏和气喘症状，从而增加了对Montelukast sodium的需求。医疗基础设施的改善和治疗指南的建议也进一步推动了市场扩张。此外，对创新製剂和联合治疗的持续研究有望扩大Montelukast的应用范围。人工智慧 (AI) 在药物研发中的应用、物联网 (IoT) 在储存条件监控中的应用以及区块链在供应链透明度方面的应用等技术创新也在推动市场发展。这些创新不仅提高了药物的安全性和可近性，也有助于企业在製药业保持竞争优势。

全球Montelukast sodium市场驱动因素

全球Montelukast sodium市场成长的主要驱动因素是呼吸系统疾病（包括气喘和过敏性鼻炎）发生率的上升，以及空气污染、吸烟、遗传因素和生活方式改变等因素。随着空气污染加剧、都市化加快、气候变迁和遗传易感性等因素导致越来越多的人患有慢性呼吸系统疾病，对Montelukast sodium等有效药物的需求也日益增长。这种日益加重的健康负担使得呼吸系统疾病的治疗方法需求显着增加，进一步推动了这个重要治疗领域的市场成长和扩张。

限制全球Montelukast sodium市场发展的因素

由于缺乏专利保护，Montelukast sodium市场面临严峻挑战，导致生产商之间竞争异常激烈。学名药价格大幅降低，对品牌Montelukast sodium的销售造成了负面影响。此外，低价进口Montelukast sodium的涌入进一步加剧了市场竞争，限制了国内生产商的成长机会。因此，这些因素阻碍因素了市场扩张，使得品牌产品难以在价格较低的替代品面前维持市场份额。这种竞争格局对Montelukast sodium市场构成了重大限制。

全球Montelukast sodium市场趋势

随着专利到期，全球Montelukast sodium市场正经历显着的变革时期，学名药产量激增。这一趋势的特点是，人们越来越倾向于选择疗效相同、价格更低的替代药物，这使得非专利Montelukast sodium对患者、医疗服务提供者和政府医疗系统都极具吸引力。随着多家製药公司携各自的非专利药进入市场，竞争日益激烈，价格也随之下降，药物的可及性也得到提升。此外，严格的法规结构正在实施，以确保这些学名药保持其安全性和有效性，最终创造出一个更充满活力、更人性化的市场环境。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 案例研究
• 顾客购买行为分析

全球Montelukast sodium市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 吸入器
  • 干粉
  • 计量喷雾型
  • 缓雾
• 喷雾器

全球Montelukast sodium市场规模（依剂型划分）及复合年增长率（2026-2033 年）

• 药片
• 口服液
• 其他的

全球Montelukast sodium市场规模（按药物类别和复合年增长率划分）（2026-2033 年）

• 抗发炎药
• 支气管扩张剂
• 联合治疗

全球Montelukast sodium市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 气喘
• 过敏性鼻炎
• 麻疹
• 其他用途

全球Montelukast sodium市场规模（依通路划分）及复合年增长率（2026-2033 年）

• 医院药房
• 零售药房
• 网路药房

全球Montelukast sodium市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Teva Pharmaceuticals USA Inc.（US）
• Merck & Co. Inc.（US）
• Cipla Limited（India）
• Morepen Laboratories（India）
• Sanofi Aventis SA（France）
• SUN PHARMA（India）
• Intas Pharmaceuticals Ltd（India）
• Delmar Chemicals Inc.（Canada）
• SK Capital（Apotex Inc）（Canada）
• Sanyo Chemical Industries Ltd（Japan）

结论与建议

Global Montelukast Sodium Market size was valued at USD 527.39 Billion in 2024 and is poised to grow from USD 607.02 Billion in 2025 to USD 1869.86 Billion by 2033, growing at a CAGR of 15.1% during the forecast period (2026-2033).

The global montelukast sodium market is witnessing significant growth driven by the rising prevalence of respiratory conditions such as asthma and allergic rhinitis, coupled with an aging population more susceptible to these ailments. Increasing air pollution levels are exacerbating allergy and asthma cases, thereby boosting demand for montelukast sodium. Improvements in healthcare infrastructure and its endorsement in treatment guidelines further support market expansion. Additionally, ongoing research into innovative formulations and combination therapies is likely to broaden montelukast's applicability. The market is also evolving through technological advancements, including AI for drug development, IoT for monitoring storage conditions, and blockchain for supply chain transparency. These innovations not only enhance safety and accessibility but also help companies maintain a competitive edge in the pharmaceutical landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Montelukast Sodium market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Montelukast Sodium Market Segments Analysis

Global Montelukast Sodium Market is segmented by Product Type, Dosage Form, Drug Class, Application, Distribution Channel and region. Based on Product Type, the market is segmented into Inhalers and Nebulizers. Based on Dosage Form, the market is segmented into Tablets, Oral solutions and Others. Based on Drug Class, the market is segmented into Anti-inflammatory, Bronchodilators and Combination Therapy. Based on Application, the market is segmented into Asthma, Allergic rhinitis, Urticaria and Other applications. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Montelukast Sodium Market

The global Montelukast Sodium market is being propelled by the rising incidence of respiratory disorders, including asthma and allergic rhinitis, along with contributing factors like air pollution, smoking, genetic factors, and lifestyle changes. As more people face chronic respiratory conditions due to heightened air pollution, urbanization, climate changes, and genetic vulnerabilities, the demand for effective medications like Montelukast Sodium is on the rise. This increased health burden creates a significant need for treatments that address these respiratory issues, further fueling market growth and expansion in this critical therapeutic area.

Restraints in the Global Montelukast Sodium Market

The Montelukast Sodium market faces significant challenges due to the absence of patent protection, resulting in fierce competition among manufacturers. The presence of generic versions, often available at substantially lower prices, adversely affects the sales of branded montelukast sodium. Additionally, the influx of affordable imported montelukast sodium further complicates the situation by limiting the growth opportunities for domestic producers. As a result, these factors create a restrictive environment for market expansion, making it difficult for branded products to maintain their market share against cheaper alternatives. This competitive landscape poses considerable constraints on the Montelukast Sodium market.

Market Trends of the Global Montelukast Sodium Market

The Global Montelukast Sodium market is experiencing a significant shift driven by the expiration of patents, leading to a surge in generic manufacturing. This trend is characterized by the increasing preference for cost-effective alternatives that deliver equivalent efficacy, making generic montelukast sodium highly appealing to patients, healthcare providers, and government health systems alike. As various pharmaceutical companies enter the market with their generic offerings, competition is intensifying, resulting in lower prices and broader accessibility. Furthermore, stringent regulatory frameworks are being implemented to ensure that these generic versions maintain safety and effectiveness, ultimately shaping a more dynamic and consumer-friendly landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Montelukast Sodium Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Inhalers
  • Dry Powder
  • Metered Dose
  • Soft Mist
• Nebulizers

Global Montelukast Sodium Market Size by Dosage Form & CAGR (2026-2033)

• Market Overview
• Tablets
• Oral solutions
• Others

Global Montelukast Sodium Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Anti-inflammatory
• Bronchodilators
• Combination Therapy

Global Montelukast Sodium Market Size by Application & CAGR (2026-2033)

• Market Overview
• Asthma
• Allergic rhinitis
• Urticaria
• Other applications

Global Montelukast Sodium Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Global Montelukast Sodium Market Size & CAGR (2026-2033)

• North America (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Teva Pharmaceuticals USA Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morepen Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Aventis SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SUN PHARMA (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Delmar Chemicals Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SK Capital (Apotex Inc) (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanyo Chemical Industries Ltd (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations